Pharmaceutical Executive Editorial Staff

Acquisition will enhance Ashfield's Patient Solutions offering.

Multi-year strategic research collaboration leverages Obsidian’s proprietary cytoDRiVE platform to discover controllable genetic therapies to treat serious diseases.

Next tier of markets is poised to ascend and offer valuable opportunities to both investors and occupiers.

New product expands outreach of medical affairs organizations.

Research shows ESG performance is strongly predictive of long-term value creation and financial performance, when a sector-specific approach is maintained.

Report provides comprehensive look at financial and accounting issues faced by life sciences industry.

New initiative from late-stage research and patient-support services organization aims to accelerate COVID-19 vaccine development.

Week-long event aims to help commercialize innovations to reach patients in need.

With a complicated and challenging global picture greeting the new year, driven by the continuing pandemic and historic political and regulatory changes in the US and Europe, we outline eight diverse trends critical to biopharma’s future health and growth.

Survey shows providers have embraced telemedicine, but are experiencing higher rates of burnout.

GlobalData releases report on the physician's perspective of telemedicine.

Women’s leadership and mentoring initiatives garner Healthcare Businesswomen’s Association top honors for BD, GSK, Surgical Care Affiliates, and Walgreens Boots Alliance.

Pharm Exec presents the diverse stories of 11 rising biopharma managers.

Pharm Exec’s annual forecast of the key issues facing biopharma leaders in the year ahead taps experts from several areas to uncover the seven new-decade trends to watch.

Hari Pujar, chief technology officer of Spark Therapeutics, discusses the unique manufacturing and scale-up challenges involved with cell and gene therapy production.

Pharm Exec’s annual look at what lies ahead for the biopharma industry in the coming months examines eight key trends that are seemingly at tipping points in their evolution and poised to shape the life sciences landscape in 2019.

Pharm Exec’s 11th annual list of rising leaders highlights 10 pharma managers who are poised to help chart the industry’s path forward.

In our annual temperature check on the life sciences sector and its outlook for the months ahead, we explore eight trends that will shape the biopharma industry landscape in 2018.

Pharm Exec’s 10th annual list of rising leaders highlights 11 pharma managers who are poised to help chart the industry’s path forward.

Pharm Exec’s 9th annual list of rising industry leaders illustrates how the deployment of essential human capital has changed in line with a business model that is no longer static and predictable-or complacent.